DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,112,000 | -52.7% | 700,000 | -12.5% | 0.32% | -47.9% |
| Q2 2021 | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% |
| Q1 2021 | $20,456,000 | +85.7% | 800,000 | +60.0% | 0.36% | -15.3% |
| Q4 2019 | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| Q3 2019 | $14,360,000 | -8.8% | 1,000,000 | 0.0% | 0.58% | -9.6% |
| Q2 2019 | $15,750,000 | +9.8% | 1,000,000 | +2.1% | 0.64% | +8.7% |
| Q1 2019 | $14,346,000 | +155.6% | 979,275 | +86.5% | 0.59% | +181.7% |
| Q4 2018 | $5,612,000 | -13.5% | 525,000 | +23.5% | 0.21% | +23.1% |
| Q3 2018 | $6,486,000 | +24.6% | 425,000 | 0.0% | 0.17% | +52.3% |
| Q2 2018 | $5,206,000 | +28.1% | 425,000 | 0.0% | 0.11% | +117.6% |
| Q1 2018 | $4,063,000 | – | 425,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |